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Study of Cytokine Profile in Oral Submucous Fibrosis Tissues:  
Unveiling a Novel Pathogenesis 
 Oral submucous fibrosis (OSF) is a chronic fibrotic disease of the oral cavity and oropharynx. This 
condition affects approximately 0.5% of the 
population in the Indian subcontinent.  
 
Various  molecules have been proposed in OSF's 
pathogenesis, involving cytokines and chemokines. 
 
These cytokines can induce chemotactic movement 
of immune cells towards the fibrotic tissue. The 
transcription factors like CREB, NFAT5, and NF-κB  
are responsible for activation of chemokines.  
 
This study is regarding the transcriptional readiness 
of fibrotic cells from OSF to produce various 
chemokines, which in turn create favorable 
microenvironment for chronic pathogenesis of OSF. 
 
Conclusion: The elevated expression of transcription factors and chemokines can be a 
critical molecular finding about their role in pathogenesis of OSF. OSF stage-specific levels 
of various chemokines indicate that during the progression of OSF, the secretory profile 
of fibrotic cells changes with regard to chemokines.  
Hypothesis: 
It has been hypothesized that cytokine 
and chemokine levels are altered in 
particular pattern in tissue samples of 
various groups of OSF. 
Results: 
CXCL11, CXCL9, and CCL2 elevated in early stage of 
OSF. 
CCL3, CXCL10, and CXCL8 elevated in late stage of 
OSF. 
CREB, NFAT5, and NF - k elevated in late stage. 
Future implications:  
The result of this study explains cytokine 
based novel pathogenesis for OSF. 
Gives direction about therapeutic intervention 
targeting cytokines or its activators for OSF 
management that can prevent the disease 
initiation and progression. 
In future, follow up studies will unveil the role 
of cytokines and chemokines (possibly panel 
of them) as predictive biomarkers of malignant 
transformation.  
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